New CEO takes charge at Tecan
Switzerland's Tecan has appointed a new CEO, Aitor Galdos, four
months after the abrupt departure of the former post-holder Emile
FtsZ blocker developed at Merck
Researchers at Merck Research Laboratories have discovered a
small-molecule drug that blocks the activity of FtsZ, an emerging
therapeutic target for antibacterial agents.
BioRobotics bought by US firm
Harvard Bioscience expands in Europe by acquiring UK DNA microarray
and colony picking instrument firm BioRobotics for $3.2 million
SBS: new product round-up
New products unveiled as the SBS annual meeting gets underway
include systems for high-throughput screening, genotyping and patch
Explosion at Sigma-Aldrich plant
A production facility operated by Sigma-Aldrich was rocked by a
serious explosion on Monday. There were no casualties, but the
facility itself has been 'largely destroyed'.
Boom expected in cell culture reagents
The US market for media, sera and reagents used in cell culture is
expected to nearly double in value to reach $1.7 billion (€1.48bn)
in 2008, according to a report.
UK benefiting from German reform?
Healthcare reform and cost containment affecting the rest of Europe
are making the UK increasingly attractive to the branded
CRO industry coming under pressure
Contract research organisation (CRO) revenues have been growing
strongly as a result of drug developers' need to reduce R&D
costs while shortening product evaluation times. However, as demand
for more efficient preclinical...
Drug treatment for CJD?
Quinacrine could provide the first drug treatment for
prion-associated disorders such as Creutzfeldt-Jakob disease,
according to new research presented at ICAAC.
Gene alliance targets diabetes
Roche forges an alliance with ParAllele to discover genes that
contribute to type 2 diabetes, aimed at identifying potential new
medicines and diagnostics for the disease.
SBS: product preview
Next week's Society for Biomolecular Screening annual meeting will
once again be a showcase for dozens of new products in the drug
discovery arena. We preview some of the highlights.
Breathe in the genes
New research has suggested that it may be possible to deliver
therapeutic DNA to the lung using a simple pressurised metered dose
Genevac of the UK has introduced a high performance Model HT-4X
centrifugal evaporator for scientists in the drug discovery and
medicinal chemistry sectors.
Sweden's Nanoxis has secured a financing deal that will help it
develop nanoanalytical platforms - so-called proteinchips - for the
identification of proteins in drug discovery.
AnaSpec buys fluorescence firm
Peptide and antibody specialist AnaSpec has acquired HiLyte
Biosciences, which makes bioanalytical research reagents and kits
designed for scientists engaged in life science research and drug